Tobramycin inhalation powder: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
about
Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.Dry powder inhalers in COPD, lung inflammation and pulmonary infections.Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacinEconomic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis.Carbon Sources Tune Antibiotic Susceptibility in Pseudomonas aeruginosa via Tricarboxylic Acid Cycle Control.
P2860
Tobramycin inhalation powder: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Tobramycin inhalation powder: ...... patients with cystic fibrosis.
@en
type
label
Tobramycin inhalation powder: ...... patients with cystic fibrosis.
@en
prefLabel
Tobramycin inhalation powder: ...... patients with cystic fibrosis.
@en
P2860
P1433
P1476
Tobramycin inhalation powder: ...... patients with cystic fibrosis.
@en
P2093
Kate McKeage
P2860
P2888
P304
P356
10.1007/S40265-013-0141-0
P577
2013-11-01T00:00:00Z
P6179
1043368837